Scholar Rock Holding Co. (NASDAQ:SRRK) Given Consensus Rating of “Buy” by Brokerages

Scholar Rock Holding Co. (NASDAQ:SRRK) has been given a consensus recommendation of “Buy” by the six ratings firms that are covering the stock, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $25.17.

A number of brokerages have recently weighed in on SRRK. HC Wainwright restated a “buy” rating and issued a $30.00 target price on shares of Scholar Rock in a research note on Tuesday, March 19th. Raymond James began coverage on Scholar Rock in a research report on Thursday, March 28th. They set a “strong-buy” rating and a $30.00 target price for the company. Truist Financial restated a “buy” rating and set a $20.00 target price on shares of Scholar Rock in a research report on Wednesday, April 3rd. Piper Sandler reiterated an “overweight” rating and set a $28.00 price objective on shares of Scholar Rock in a report on Tuesday, March 26th. Finally, Wedbush reiterated an “outperform” rating and set a $23.00 price objective on shares of Scholar Rock in a report on Tuesday, January 23rd.

Insider Buying and Selling at Scholar Rock

In other Scholar Rock news, CFO Edward H. Myles sold 4,744 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total value of $74,670.56. Following the sale, the chief financial officer now owns 210,976 shares in the company, valued at approximately $3,320,762.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CFO Edward H. Myles sold 4,744 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total transaction of $74,670.56. Following the sale, the chief financial officer now owns 210,976 shares in the company, valued at approximately $3,320,762.24. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel Junlin Ho sold 3,489 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total value of $54,916.86. Following the sale, the general counsel now owns 208,771 shares in the company, valued at approximately $3,286,055.54. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,359 shares of company stock worth $351,931. Corporate insiders own 26.20% of the company’s stock.

Institutional Investors Weigh In On Scholar Rock

Institutional investors and hedge funds have recently made changes to their positions in the stock. Swiss National Bank increased its holdings in shares of Scholar Rock by 9.3% during the 1st quarter. Swiss National Bank now owns 54,000 shares of the company’s stock worth $696,000 after acquiring an additional 4,600 shares during the last quarter. MetLife Investment Management LLC grew its holdings in Scholar Rock by 54.1% in the 1st quarter. MetLife Investment Management LLC now owns 16,604 shares of the company’s stock valued at $214,000 after buying an additional 5,832 shares in the last quarter. Rhumbline Advisers grew its holdings in Scholar Rock by 7.0% in the 1st quarter. Rhumbline Advisers now owns 29,405 shares of the company’s stock valued at $379,000 after buying an additional 1,918 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Scholar Rock by 23.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 178,984 shares of the company’s stock valued at $2,307,000 after buying an additional 34,416 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in Scholar Rock by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 1,490,795 shares of the company’s stock valued at $19,217,000 after buying an additional 38,917 shares in the last quarter. Institutional investors own 91.08% of the company’s stock.

Scholar Rock Trading Down 0.7 %

Shares of SRRK stock opened at $13.85 on Monday. Scholar Rock has a 12 month low of $5.56 and a 12 month high of $21.17. The company has a quick ratio of 8.80, a current ratio of 8.80 and a debt-to-equity ratio of 0.22. The business’s 50 day moving average is $15.44 and its two-hundred day moving average is $14.36. The company has a market cap of $1.08 billion, a PE ratio of -6.96 and a beta of 0.90.

Scholar Rock (NASDAQ:SRRK) last issued its earnings results on Tuesday, March 19th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Equities analysts predict that Scholar Rock will post -2.01 EPS for the current year.

About Scholar Rock

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.